Render Target: SSR
Render Timestamp: 2024-12-19T21:25:37.497Z
Commit: f2d32940205a64f990b886d724ccee2c9935daff
XML generation date: 2024-10-30 20:01:10.197
Product last modified at: 2024-09-20T14:30:08.080Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Antibody Sampler Kit
PDP - Template ID: *******4a3ef3a

N6-Methyladenosine (m6A) Binding Protein Antibody Sampler Kit #80523

    Product Information

    Product Description

    The N6-Methyladenosine (m6A) Binding Protein Antibody Sampler Kit provides an economical means of evaluating total levels of YTH domain-containing proteins. The kit includes enough antibodies to perform two western blot experiments with each primary antibody.

    Specificity / Sensitivity

    Each antibody in the N6-Methyladenosine (m6A) Binding Protein Antibody Sampler Kit detects endogenous levels of its target protein. Experiments utilizing overexpression constructs indicated that YTHDF3 Antibody may weakly cross-react with YTHDF1.

    Source / Purification

    Monoclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly90 of human YTHDF1 protein, Gly167 of human YTHDF2 protein, Phe557 of human YTHDC1 protein, and Gly1243 of human YTHDC2 protein. Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly169 of human YTHDF3 protein, and are purified by peptide affinity chromatography.

    Background

    N6-methyladenosine (m6A) is an abundant RNA modification that plays an important role in mRNA splicing, processing, and stability. The m6A modification is specifically recognized by YT521B homology (YTH) domain-containing proteins, consisting of five members in mammals: YTH domain-containing proteins 1 and 2 (YTHDC1 and YTHDC2), and YTH domain-containing family proteins 1, 2, and 3 (YTHDF1, YTHDF2, and YTHDF3) (1). YTHDC1, also known as splicing factor YT521, regulates alternative splicing by functioning as a key regulator of exon-inclusion or exon-skipping. YTHDC1 promotes exon-inclusion by recruiting pre-mRNA splicing factor SRSF3 to regions containing m6A, while repressing exon-skipping by blocking SRSF10 binding to these same regions (2). Increased expression of YTHDC1 promotes malignant endometrial carcinoma (EC) through alternative splicing of vascular endothelial growth factor-A (VEGF-A), resulting in an increase in VEGF-165 isoform and increased EC cell invasion (3). YTHDC2 functions to enhance the translation efficiency of target mRNAs and may play a role in spermatogenesis (4). All three members of the YTHDF family are paralogs that share similar sequence and domain structure, including the conserved C-terminal YTH domain that specifically interacts with m6A (5). Despite these similarities, recent studies suggest that YTHDF proteins are involved in distinct regulatory functions with minimal overlap. Specifically, YTHDF1 binding has been reported to promote enhanced mRNA translation, but has no measurable effect on mRNA stability (6). Conversely, YTHDF2 binding appears to promote mRNA degradation, but has minimal effect on translation efficiency (7). The function of YTHDF3 is less clear, but it has been proposed to function as an auxiliary protein for both YTHDF1 and YTHDF2, helping to promote either increased mRNA translation or decay, respectively (8). Additional studies offer a different viewpoint, suggesting that all three YTHDF proteins initiate mRNA degradation, or mediate increased mRNA stability and protein expression, promoting the idea that these proteins may carry out similar rather than distinct functions (9,10).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.